首页> 美国卫生研究院文献>other >Multiplexed Molecular Imaging of Biomarker-Targeted SERS Nanoparticles on Fresh Tissue Specimens with Channel-Compressed Spectrometry
【2h】

Multiplexed Molecular Imaging of Biomarker-Targeted SERS Nanoparticles on Fresh Tissue Specimens with Channel-Compressed Spectrometry

机译:通道压缩光谱法在新鲜组织标本上靶向生物标志物的SERS纳米颗粒的多分子成像

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Biomarker-targeted surface-enhanced Raman scattering (SERS) nanoparticles (NPs) have been explored as a viable option for targeting and imaging multiple cell-surface protein biomarkers of cancer. While it has been demonstrated that this Raman-encoded molecular imaging (REMI) technology may potentially be used to guide tumor-resection procedures, the REMI strategy would benefit from further improvements in imaging speed. Previous implementations of REMI have utilized 1024 spectral channels (camera pixels) in a commercial spectroscopic CCD to detect the spectral signals from multiplexed SERS NPs, a strategy that enables accurate demultiplexing of the relative concentration of each NP “flavor” within a mixture. Here, we investigate the ability to significantly reduce the number of spectral-collection channels while maintaining accurate imaging and demultiplexing of up to five SERS NP flavors, a strategy that offers the potential for improved imaging speed and/or detection sensitivity in future systems. This strategy was optimized by analyzing the linearity of five multiplexed flavors of SERS NPs topically applied on tissues. The accuracy of this binning approach was then validated by staining tumor xenografts and human breast tumor specimens with a mixture of five NP flavors (four targeted NPs and one untargeted NP) and performing ratiometric imaging of specific vs. nonspecific NP accumulation. We demonstrate that with channel-compressed spectrometry using as few as 16 channels, it is possible to perform REMI with five NP flavors, with < 20% error, at low concentrations (< 10 pM) that are relevant for clinical applications.
机译:针对生物标志物的表面增强拉曼散射(SERS)纳米粒子(NPs)已被研究为靶向和成像癌症的多种细胞表面蛋白质生物标志物的可行选择。尽管已证明该拉曼编码分子成像(REMI)技术可能会用于指导肿瘤切除程序,但REMI策略将从成像速度的进一步提高中受益。 REMI的先前实现已在商业光谱CCD中利用了1024个光谱通道(相机像素)来检测来自多路复用SERS NP的光谱信号,该策略可对混合物中每个NP“味道”的相对浓度进行精确解复用。在这里,我们研究了显着减少光谱收集通道数量的能力,同时保持了多达五个SERS NP口味的精确成像和多路分解,这一策略为提高未来系统的成像速度和/或检测灵敏度提供了可能。通过分析局部应用在组织上的5种SERS NP的多重风味的线性,优化了该策略。然后通过用五种NP风味剂的混合物(四种靶向NP和一种非靶向NP)对肿瘤异种移植物和人乳腺肿瘤标本进行染色,并对特异性和非特异性NP积累进行比例成像,来验证这种分类方法的准确性。我们证明了使用少至16个通道的通道压缩光谱仪,可以在与临床应用相关的低浓度(<10 pM)下以5种NP风味进行REMI,误差<20%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号